NAVB

Navidea Biopharmaceuticals Inc.
NAVB

Overview Fund Activity
Delisted

NAVB was delisted on the 5th of October, 2023.

Back to rankings

24 hedge funds and large institutions have $226K invested in Navidea Biopharmaceuticals Inc. in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 3 closing their positions.

Holders
24
Holders Change
+1
Holders Change %
+4.35%
% of All Funds
0.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VF
1
Virtu Financial
New York
$30K
2
Geode Capital Management
2
Geode Capital Management
Massachusetts
$33.1K
3
WAM
3
Warberg Asset Management
Illinois
$17.5K
4
ACM
4
Allred Capital Management
Texas
$41.9K
5
UBS Group
5
UBS Group
Switzerland
$13.5K

Top Sellers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$0
2
TSS
2
Two Sigma Securities
New York
$2.83K
3
CSS
3
Cubist Systematic Strategies
Connecticut
$0
4
JPMorgan Chase & Co
4
JPMorgan Chase & Co
New York
$116
5
Northwestern Mutual Wealth Management
5
Northwestern Mutual Wealth Management
Wisconsin
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
CSS
26
Cubist Systematic Strategies
Connecticut
– -$920 -10,003 Closed
Northwestern Mutual Wealth Management
27
Northwestern Mutual Wealth Management
Wisconsin
– -$10 -110 Closed
1
2